74 related articles for article (PubMed ID: 9784115)
1. Potent cyano and carboxamido side-chain analogues of 1', 1'-dimethyl-delta8-tetrahydrocannabinol.
Singer M; Ryan WJ; Saha B; Martin BR; Razdan RK
J Med Chem; 1998 Oct; 41(22):4400-7. PubMed ID: 9784115
[TBL] [Abstract][Full Text] [Related]
2. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.
Martin BR; Jefferson R; Winckler R; Wiley JL; Huffman JW; Crocker PJ; Saha B; Razdan RK
J Pharmacol Exp Ther; 1999 Sep; 290(3):1065-79. PubMed ID: 10454479
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'.
Papahatjis DP; Nikas SP; Kourouli T; Chari R; Xu W; Pertwee RG; Makriyannis A
J Med Chem; 2003 Jul; 46(15):3221-9. PubMed ID: 12852753
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.
Papahatjis DP; Kourouli T; Abadji V; Goutopoulos A; Makriyannis A
J Med Chem; 1998 Mar; 41(7):1195-200. PubMed ID: 9544219
[TBL] [Abstract][Full Text] [Related]
5. Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids.
Papahatjis DP; Nahmias VR; Andreou T; Fan P; Makriyannis A
Bioorg Med Chem Lett; 2006 Mar; 16(6):1616-20. PubMed ID: 16387492
[TBL] [Abstract][Full Text] [Related]
6. Unsaturated side chain beta-11-hydroxyhexahydrocannabinol analogs.
Busch-Petersen J; Hill WA; Fan P; Khanolkar A; Xie XQ; Tius MA; Makriyannis A
J Med Chem; 1996 Sep; 39(19):3790-6. PubMed ID: 8809166
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationship of substitutions at the C-1 position of Delta9-tetrahydrocannabinol.
Burdick D; DeOrazio R; Guzzo P; Habershaw A; Helle M; Paul B; Wolf M
Bioorg Med Chem Lett; 2010 Feb; 20(4):1424-6. PubMed ID: 20079638
[TBL] [Abstract][Full Text] [Related]
8. Exploring the substituent effects on a novel series of C1'-dimethyl-aryl Delta8-tetrahydrocannabinol analogs.
Krishnamurthy M; Gurley S; Moore BM
Bioorg Med Chem; 2008 Jul; 16(13):6489-500. PubMed ID: 18524604
[TBL] [Abstract][Full Text] [Related]
9. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
[TBL] [Abstract][Full Text] [Related]
10. Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptor.
Huffman JW; Bushell SM; Joshi SN; Wiley JL; Martin BR
Bioorg Med Chem; 2006 Jan; 14(1):247-62. PubMed ID: 16165365
[TBL] [Abstract][Full Text] [Related]
11. Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues.
Griffin G; Williams S; Aung MM; Razdan RK; Martin BR; Abood ME
Br J Pharmacol; 2001 Jan; 132(2):525-35. PubMed ID: 11159703
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
Compton DR; Rice KC; De Costa BR; Razdan RK; Melvin LS; Johnson MR; Martin BR
J Pharmacol Exp Ther; 1993 Apr; 265(1):218-26. PubMed ID: 8474008
[TBL] [Abstract][Full Text] [Related]
13. Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas.
Ng EW; Aung MM; Abood ME; Martin BR; Razdan RK
J Med Chem; 1999 Jun; 42(11):1975-81. PubMed ID: 10354405
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of indole- and pyrrole-derived cannabinoids.
Wiley JL; Compton DR; Dai D; Lainton JA; Phillips M; Huffman JW; Martin BR
J Pharmacol Exp Ther; 1998 Jun; 285(3):995-1004. PubMed ID: 9618400
[TBL] [Abstract][Full Text] [Related]
15. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.
Millan MJ; Dekeyne A; Newman-Tancredi A; Cussac D; Audinot V; Milligan G; Duqueyroix D; Girardon S; Mullot J; Boutin JA; Nicolas JP; Renouard-Try A; Lacoste JM; Cordi A
J Pharmacol Exp Ther; 2000 Dec; 295(3):1192-205. PubMed ID: 11082457
[TBL] [Abstract][Full Text] [Related]
16. Potent anandamide analogs: the effect of changing the length and branching of the end pentyl chain.
Ryan WJ; Banner WK; Wiley JL; Martin BR; Razdan RK
J Med Chem; 1997 Oct; 40(22):3617-25. PubMed ID: 9357528
[TBL] [Abstract][Full Text] [Related]
17. Behavioral effects of the novel cannabinoid full agonist AM 411.
McLaughlin PJ; Lu D; Winston KM; Thakur G; Swezey LA; Makriyannis A; Salamone JD
Pharmacol Biochem Behav; 2005 May; 81(1):78-88. PubMed ID: 15894067
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacology of the isomeric methylheptyl-delta8-tetrahydrocannabinols.
Huffman JW; Liddle J; Duncan SG; Yu S; Martin BR; Wiley JL
Bioorg Med Chem; 1998 Dec; 6(12):2383-96. PubMed ID: 9925296
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
20. 3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor.
Huffman JW; Liddle J; Yu S; Aung MM; Abood ME; Wiley JL; Martin BR
Bioorg Med Chem; 1999 Dec; 7(12):2905-14. PubMed ID: 10658595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
